HAIFA, Israel, March 9, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced its participation in the Roth 22nd Annual OC Growth Conference to be held at The Ritz-Carlton in Laguna Niguel, CA, March 15-17. William R. Prather RPh, MD, Senior VP Corporate Development, will deliver a presentation on Wednesday, March 17 at 9:00 a.m. PT/12:00 p.m. ET which can be viewed live at http://www.wsw.com/webcast/roth23/psti/">http://www.wsw.com/webcast/roth23/psti/ or through the investor relations section of Pluristem's website at www.pluristem.com. The presentation will be archived for 90 days.
The Pluristem Therapeutics Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6882
About Pluristem
Pluristem is a clinical stage biotechnology company with proprietary technology for the development and manufacturing of standardized cell therapies derived from the human placenta. Pluristem's patented and scalable PLX (PLacental eXpanded) cell product candidates are developed as readily available for the treatment of critical limb ischemia (CLI) and other diseases.